Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Eurosafe

Eurosafe is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 2 service areas.

View Eurosafe on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Bioimaging

  • Bioimaging Visualize biological process non-invasively in real time.
  • Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
  • Microscopy Use microscopy to analyze surfaces of biological materials and to develop 3D images of biological structures.

Biomarkers

  • Basic Metabolic Profiling Set up assays that monitor drug metabolite formation after administration of drug to an animal model or patient.
  • Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
  • Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
  • Human Primary Cell Isolation Isolate primary cells from various human tissues.
  • Single Cell quantitative Real Time-PCR Assess gene expression levels and patterns in a single cell.

Cell Culture and Characterization

  • Cell Culture Culture primary or immortalized cell lines.
  • Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.

Chemical and Compound Analysis

  • Adsorption/Desorption Studies Obtain data on groundwater risk assessment.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Light Sheet Fluorescence Microscopy Use a planar sheet of light to section transparent tissues and generate a 3D image.
  • MALDI-TOF Analysis Use mass spectrometry technique to analyze compound, biomolecules and large organic molecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • Phototoxicity & Photosensitization Test Test the potential for a product to elicit a reaction under UV exposure.
Show all 10 in Chemical and Compound Analysis 4 more
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.
  • UV-Spectroscopy Conduct sample analysis based on light absorption and transmission.
Show all 109 services 93 more

Chemical and Compound Testing

  • Product Testing Ensure product quality standards are met.

Chemistry, Manufacturing and Controls (CMC)

  • Plant Extracts Acquire plant extracts, such as lutein, lycopene, and quinine, to use as ingredients in consumer healthcare products.
  • Subcellular Fraction Test System Obtain human, minipig, mouse, or rat dermal microsomes as in-stock standard test systems for the development of safer topical and transdermal products.

Clinical Trials

  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
  • Consumer Healthcare Product Trials Conduct clinical research to ensure the safety and efficacy of consumer healthcare products used for oral care, skin care, nutrition, and hair care.

Data Science/Bioinformatics

  • In Silico ADME-PK Consultation Consult with experts for ADME-PK data analysis or predictive modelling design in different in vivo or in vitro states.
  • In Silico ADME-PK Predictions Use computer software to simulate in vivo physiological conditions of animals or humans to predict ADME-PK properties.
  • In Silico Drug-Drug Interactions Use computational tools to predict pharmaceutical, pharmacodynamic or pharmacokinetic drug-drug interactions to maximize drug regimen safety.
  • In Silico Pro-drug Predictions Use computer simulation to assess pro-drug absorption and conversion to predict pharmacokinetic properties.
  • In Silico Protein Modification Analysis Use computational methods to predict the behavior of modified proteins.
  • In Silico Protein Sequence Analysis Use software to predict protein structural and functional features and secondary structure components.

Discovery Chemistry

  • Compound Docking Identify potential compound hits based on the 3D structure of a target protein.
  • Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
  • In Silico Metabolite Predictions Conduct in silico assessment of metabolite pharmacokinetic properties and potential exposure effects.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
  • Pharmacophore Modeling Use computer models to identify hits based on structural similarity to known active compounds.
Show all 8 in Discovery Chemistry 2 more
  • QSAR Analysis Develop quantitative structure–activity relationship models for drug design.
  • Virtual Screening Use software algorithms to virtually screen millions of potential compounds and peptides for binding.

Disease Models

  • Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.

DNA & RNA

  • qPCR Analysis Measure the accumulation of PCR products in real time.

General Marketing

  • Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
Show all 27 in In Vitro ADME 21 more
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Multidrug Resistance Identify potential causes of drug-drug interactions.
  • Ocular Permeability Measure passive diffusion and active transport of drugs across confluent ocular epithelial cells.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.

In Vitro Assays

  • Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
  • Cell Based Assays Consulting Expert advice to evaluate the functions of specific chemicals based on their constructions and systems.
  • Cell Proliferation Measure cell number, cell viability and cell division.
  • In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.
  • In Vitro SPF (Sun Protection Factor) Testing Use in vitro test methods to measure the UVA protection performance of sun protection products.
  • Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.

In Vitro Pharmacology

  • ATP Competitive Study Determine whether or not a compound is competitive with ATP.
  • In Vitro Enzyme Activity Assay Development Develop new in vitro enzyme activity assays or modify existing ones.
  • In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
  • Solute-Linked Carrier (SLC) Transporter Inhibition Assays Use biochemical, cell-based or in vivo assays to measure solute-linked carrier transporter activity.
  • Solute-Linked Carrier (SLC) Transporter Substrate Identification Use biochemical, cell-based or in vivo assays to identify solute-linked carrier transporter substrates.
  • Substrate Competitive Study Determine whether or not a compound is competitive with a substrate.
Show all 8 in In Vitro Pharmacology 2 more
  • Time Dependent Study Determine whether or not a compound binds to an enzyme in a time-dependent manner.
  • UDP-glucuronosyltransferases (UGT) Inhibition Assays Use biochemical, cell-based or in vivo assays to measure UDP-glucuronosyltransferase activity.

In Vitro Toxicology

  • Cytotoxicity Test for effects on cell viability and proliferation
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
  • HepaRG Cells Obtain terminally differentiated and cryopreserved hepatic cells that retain many characteristics of primary human hepatocytes.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.

Lab Supplies, Facilities, and Equipment

  • Biobanking Store and track biological samples.

Other Specialty Toxicology

  • Phototoxicity Determine whether drug treatment causes light-activated toxic effects.

Protein Sciences

  • Mass Spectrometry-Based Proteomics Detect histone post-translational modifications (hPTMs), histone variants, and interactomes at chromatin regions.
  • Protein Binding Determine drug-protein binding interactions

Raw Materials

  • Oral Health Care Product Ingredients Acquire ingredients for making oral healthcare products.

REACH Services

  • OECD 432: In Vitro 3T3 NRU Phototoxicity Test Test the cytotoxic effects of chemical substances and environmental samples on cell membranes.
  • OECD 471: Bacterial Reverse Mutation Test (Ames) Measure the mutagenic potential of test compounds.
  • OECD 489: In Vivo Mammalian Alkaline Comet Assay Measure the mitogenic and genotoxic potential of test compounds.

Scientific Data Services

  • In Silico Genomics/Transcriptomics Data Analysis Interpret DNA sequencing and microarray data.
  • In Silico Metagenomics/Metatranscriptomics Data Analysis Use software to analyze genomic information from multiple environmental sources.

Testing Services

  • Freeze-Thaw Testing Use freeze-thaw cycling to measure the long-term durability of cosumer products.
  • Human Repeat Insult Patch Test (HRIPT) Examples of which include Topical Irritation, Allergenicity, Phototoxicity and Photoallergy testing.
  • Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.
  • Ocular Irritation Test Use human subjects to determine whether a cosmetic product or ingredient can cause ocular irritation.
  • OECD 442C: Direct Peptide Reactivity Assay (DPRA) Determine whether a test article satisfies the protein-binding criterion for skin sensitizers.
  • OECD 442E: Human Cell Line Activation Test (h-CLAT) In vitro skin sensitization test to predict skin sensitization potency.
Show all 11 in Testing Services 5 more
  • OECD TG 492: Ocular Irritation Testing Use in vitro skin models to determine whether a product can cause dermal sensitization (e.g. EpiOcular Eye Irritation Test - EIT)
  • Skin Elasticity Testing Measure the skin's ability to resist pressure (firmness) and its ability to return to its original position pre- and post-treatment.
  • Skin Lightening Product Test Measure qualitative and quantitative changes in skin pigmentation under the influence of the test sample.
  • Tolerance Test Under Dermatologic Control Evaluate the acceptability and skin tolerance of a cosmetic product.
  • Trans-Epidermal Water Loss (TEWL) Use a sensing electrode encased in a chimney to measure the relative humidity percentage at the skin surface.

Other services

  • New Request  

Service areas:

DMPK Toxicology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • France Saint-Grégoire 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Xenoblis offers ADMET services including skin/intestinal permeability studies, blood brain barrier studies, genotoxicity, cytotoxicity, metabolite characterization, and protein binding studies.

Website
www.eurosafe.com

Source: Scientist.com supplier network, written by the supplier

Get the Eurosafe report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Eurosafe on Scientist.com

For prices, more details, or to contact Eurosafe, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.